2019 Life Sciences Outlook: Innovation is alive and well

Transformation is accelerating, and real estate needs to keep up

The Life Sciences industry has become a key economic driver in the U.S. and a critical component of the global economy. Biotechnology and pharmaceutical firms are revolutionizing how diseases are treated and improving quality of life for millions around the globe. A new wave of medical innovation has hit the industry, with over 7,000 medicines in clinical development worldwide and a record amount of drug approvals by the FDA. Venture capital funding to Life Sciences has surged, growing 40% in the U.S. over the past year. Even with these exciting changes come challenges. As Life Sciences companies search for the brightest employees, infrastructure, affordability and competition with technology firms mean that the war for talent is tougher than ever.

Fill out this form to download report

There was an error submitting the form. Please try again. 


Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of sending you the research you have requested.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.